StonvexLoading…
StonvexStonvexStonvexCore line items from ORCL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-05-31 | Annual 2024 2024-05-31 | Annual 2023 2023-05-31 | Annual 2022 2022-05-31 |
|---|---|---|---|---|
Revenue | $57.40B | $52.96B | $49.95B | $42.44B |
Operating Income | $17.68B | $15.35B | $13.09B | $10.93B |
Net Income | $12.44B | $10.47B | $8.50B | $6.72B |
EPS (Diluted) | $4.34 | $3.71 | $3.07 | $2.41 |
Total Assets | $168.36B | $140.98B | $134.38B | $109.30B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $10.79B | $10.45B | $9.77B | $21.38B |
Free Cash Flow OCF − CapEx | $-394.00M | $11.81B | $8.47B | $5.03B |
Shares Outstanding | 2.81B | 2.75B | 2.71B | 2.67B |